Back Close
Vaccination Acceptance Research Network

VARN2023 Conference

The Vaccination Acceptance Research Network's 2023 Conference


June 13-15, 2023 | Bangkok, Thailand | Royal Orchid Sheraton Hotel & Towers 

Registration is now open!

The Sabin Vaccine Institute and UNICEF, in partnership with Gavi, the Vaccine Alliance Present the Vaccination Acceptance Research Network (VARN) 2023 Conference

June 13-15 | Bangkok Thailand | Royal Orchid Sheraton Hotel & Towers

The Sabin Vaccine Institute’s Vaccination Acceptance Research Network (VARN) will be hosting its second annual conference co-convened with UNICEF and co-sponsored by Gavi, the Vaccine Alliance and in support of COVID-19 Vaccine Delivery Partnership priority countries. This meeting will be an in-person event with facilitation of virtual presentations as needed. Conference sessions will provide a space for exploration and facilitate the wide dissemination of a growing body of knowledge, practice, and evidence-informed strategies for driving action across the vaccination acceptance, demand and delivery ecosystem. A ‘post-live’ publishing of recorded sessions will be made available to all registrants on the conferencing website.

In 2022, Sabin’s inaugural VARN conference and the COVID-19 global demand event, co-hosted by UNICEF and partners, brought together over 1500 global experts as registered attendees across 126 countries. Participants represented diverse disciplines including global health and policy, research and academia, and healthcare and health communications.

VARN2023 will provide an opportunity for the sharing of knowledge from research and practice, as well as agenda setting around three core themes:

  1.   Vaccine equity, as it relates to zero-dose marginalized communities, conflict-settings, gender, etc.;
  2.   Recovery and reimagining childhood essential immunization, including its integration into other health service delivery programs, from the policy-level through to service delivery at community-level; and
  3.  Life-course immunization and the opportunity we have in a post-pandemic world to continue building on the value of such programs, including a focus on HPV, pandemic preparedness, and integrated approaches.

There will be specific conference sessions focused on both vaccine demand generation and social listening to mitigate rumors and misinformation about vaccines and vaccination, as these critical components cut across all core themes.

At VARN2023, we will be providing simultaneous live audio interpretation in French and English for all sessions. All posters in English and French will have translated abstract handouts provided.

Watch this space for speaker announcements and the agenda. Explore the VARN2022 conference report and recordings for insights from last year’s convening.

Frequently asked questions

The Sabin Vaccine Institute is a leading advocate for expanding vaccine access and uptake globally, advancing vaccine research and development, and amplifying vaccine knowledge and innovation. Unlocking the potential of vaccines through partnership, Sabin has built a robust ecosystem of funders, innovators, implementers, practitioners, policy makers and public stakeholders to advance its vision of a future free from preventable diseases. As a non-profit with more than two decades of experience, Sabin is committed to finding solutions that last and extending the full benefits of vaccines to all people, regardless of who they are or where they live. At Sabin, we believe in the power of vaccines to change the world.
UNICEF believes that taking people centered approaches in the design of the delivery and utilization of health programmes is fundamental to ensure that immunization and other health services are tailored to the needs of the most vulnerable, particularly in zero dose and under-vaccinated communities. To achieve this, UNICEF supports countries to develop evidence-based, locally-informed, context-specific strategies with active community participation to improve vaccine uptake.
Gavi, the Vaccine Alliance is a public-private partnership that helps vaccinate half the world’s children against some of the world’s deadliest diseases. Since its inception in 2000, Gavi has helped to immunise a whole generation – over 981 million children – and prevented more than 16.2 million future deaths, helping to halve child mortality in 73 lower-income countries. Gavi also plays a key role in improving global health security by supporting health systems as well as funding global stockpiles for Ebola, cholera, meningococcal and yellow fever vaccines. After two decades of progress, Gavi is now focused on protecting the next generation, above all the zero-dose children who have not received even a single vaccine shot. The Vaccine Alliance employs innovative finance and the latest technology – from drones to biometrics – to save millions more lives, prevent outbreaks before they can spread and help countries on the road to self-sufficiency. Learn more at and connect with Gavi on Facebook and Twitter.
Related Resources

Expand your knowledge using our growing database of resources on vaccines and immunization.